COVID-19
Weekly Updates

As the novel Coronavirus, COVID-19 sweeps the globe and garners massive media attention, Parasites Without Borders staff are curating resources in a timely ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains, to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

UnitedInResearch_Logo_white_small2

COVID-19 Testing Strategy Simulator

There are many strategies that will reduce infection in your population. Any testing will reduce your disease burden. Using this tool to compare pooling, test accuracy, testing frequency, and costs will allow you to choose the strategy best suited to your needs and your community.

November 30, 2020

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 | Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results | Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19 | A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

November 23, 2020

Immunological memory to SARS-CoV-2 assessed for greater than six months after infection | Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 | Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany | FDA Authorizes First COVID-19 Test for Self-Testing at Home

November 16, 2020

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans | Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study | FDA Authorizes Monoclonal Antibody for Treatment of COVID-19
Physician taking masked patient's blood pressure

November 5, 2020

Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology | SARS-CoV-2 direct cardiac damage through spike-mediated cardiomyocyte 3 fusion | Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.

October 26, 2020

An inflammatory cytokine signature predicts COVID-19 severity and survival | Moderna phase III clinical study protocol | Pfizer phase III clinical study protocol | Identifying Optimal COVID-19 Testing Strategies for Schools and Businesses: Balancing Testing Frequency, Individual Test Technology, and Cost

October 16, 2020

Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness | Vascular Disease and Thrombosis in SARS-CoV-2- Infected Rhesus Macaques | COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

1280px-US_CDC_logo.svg

Centers for Disease Control, US

ProMED-Logo

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

¡Done a los Parásitos Sin Fronteras hoy!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos. 

Scroll to Top